4//SEC Filing
WILLIAMS ROBERT M JR 4
Accession 0000950170-25-042866
CIK 0001832332other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 8:05 PM ET
Size
32.7 KB
Accession
0000950170-25-042866
Insider Transaction Report
Form 4
JHW Iliad Holdings LLC
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−7,792$42,544→ 5,213,094 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−46,912$256,140→ 31,388,159 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−1,842$10,149→ 1,453,948 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−39,825$219,436→ 31,435,071 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−6,614$36,443→ 5,220,886 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−2,170$11,848→ 1,451,778 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−693$3,818→ 547,274 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−19,897$109,632→ 15,705,299 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−23,438$127,971→ 15,681,861 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−817$4,461→ 546,457 total(indirect: By LLC)
Holdings
- 0
Common Stock, $0.01 par value
WILLIAMS ROBERT M JR
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−23,438$127,971→ 15,681,861 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−6,614$36,443→ 5,220,886 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−1,842$10,149→ 1,453,948 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−817$4,461→ 546,457 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−19,897$109,632→ 15,705,299 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−39,825$219,436→ 31,435,071 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−2,170$11,848→ 1,451,778 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−693$3,818→ 547,274 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−46,912$256,140→ 31,388,159 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−7,792$42,544→ 5,213,094 total(indirect: By LLC)
Holdings
- 0
Common Stock, $0.01 par value
J.H. Whitney VII, L.P.
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−23,438$127,971→ 15,681,861 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−39,825$219,436→ 31,435,071 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−19,897$109,632→ 15,705,299 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−46,912$256,140→ 31,388,159 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−7,792$42,544→ 5,213,094 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−693$3,818→ 547,274 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−6,614$36,443→ 5,220,886 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−1,842$10,149→ 1,453,948 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−2,170$11,848→ 1,451,778 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−817$4,461→ 546,457 total(indirect: By LLC)
Holdings
- 0
Common Stock, $0.01 par value
Transactions
- Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−23,438$127,971→ 15,681,861 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−6,614$36,443→ 5,220,886 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−7,792$42,544→ 5,213,094 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−39,825$219,436→ 31,435,071 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−19,897$109,632→ 15,705,299 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−46,912$256,140→ 31,388,159 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−1,842$10,149→ 1,453,948 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−2,170$11,848→ 1,451,778 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−693$3,818→ 547,274 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−817$4,461→ 546,457 total(indirect: By LLC)
Holdings
- 0
Common Stock, $0.01 par value
PSA Iliad Holdings LLC
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−46,912$256,140→ 31,388,159 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−23,438$127,971→ 15,681,861 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−7,792$42,544→ 5,213,094 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−1,842$10,149→ 1,453,948 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−2,170$11,848→ 1,451,778 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−817$4,461→ 546,457 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−39,825$219,436→ 31,435,071 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−19,897$109,632→ 15,705,299 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−6,614$36,443→ 5,220,886 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−693$3,818→ 547,274 total(indirect: By LLC)
Holdings
- 0
Common Stock, $0.01 par value
JHW Iliad Holdings II LLC
10% Owner
Transactions
- Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−23,438$127,971→ 15,681,861 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−6,614$36,443→ 5,220,886 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−1,842$10,149→ 1,453,948 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−693$3,818→ 547,274 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−817$4,461→ 546,457 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−39,825$219,436→ 31,435,071 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-18$5.51/sh−19,897$109,632→ 15,705,299 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−46,912$256,140→ 31,388,159 total(indirect: By J.H. Whitney VII, L.P.) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−7,792$42,544→ 5,213,094 total(indirect: By LLC) - Sale
Common Stock, $0.01 par value
2025-03-19$5.46/sh−2,170$11,848→ 1,451,778 total(indirect: By LLC)
Holdings
- 0
Common Stock, $0.01 par value
Footnotes (7)
- [F1]The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by J.H. Whitney VII, L.P. ("JHW VII"), PSA Healthcare Investment Holding LLC ("PSA Healthcare"), JHW Iliad Holdings LLC ("JHW Iliad"), PSA Iliad Holdings LLC ("PSA Iliad Holdings") and JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, JHW Iliad II and PSA Iliad Holdings, the "Stockholder Entities") on December 13, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.43 to $5.62. The reporting persons hereby undertake to provide, upon request, to the staff of the Securities and Exchange Commission ("SEC"), the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.40 to $5.56. The reporting persons hereby undertake to provide, upon request, to the staff of the SEC, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- [F4]J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of JHW VII and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare and PSA Iliad Holdings. As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of JHW VII, PSA Healthcare and PSA Iliad Holdings, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- [F5]Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad. As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- [F6]J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad II. As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- [F7]Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Aveanna Healthcare Holdings, Inc.
CIK 0001832332
Entity typeother
Related Parties
1- filerCIK 0001239610
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 8:05 PM ET
- Size
- 32.7 KB